115 related articles for article (PubMed ID: 6229242)
1. "Black spots" in Papua New Guinea Defence Force personnel: report of 12 cases.
Talwat EN
Australas J Dermatol; 1983 Aug; 24(2):69-70. PubMed ID: 6229242
[No Abstract] [Full Text] [Related]
2. Fixed drug eruptions to maloprim.
Tham SN; Chan HL
Singapore Med J; 1988 Jun; 29(3):300-2. PubMed ID: 2973126
[No Abstract] [Full Text] [Related]
3. Severe dapsone syndrome due to weekly maloprim.
Grayson ML; Yung AP; Doherty RR
Lancet; 1988 Mar; 1(8584):531. PubMed ID: 2893942
[No Abstract] [Full Text] [Related]
4. Drug-induced hepatotoxicity.
Noble A; MacDonald A
N Engl J Med; 1996 Mar; 334(13):864. PubMed ID: 8596564
[No Abstract] [Full Text] [Related]
5. Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.
Tee AK; Oh HM; Wee IY; Khoo BP; Poh WT
Ann Acad Med Singap; 2004 May; 33(3):375-8. PubMed ID: 15175785
[TBL] [Abstract][Full Text] [Related]
6. Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine.
Cook IF; Kish MY
Med J Aust; 1985 Aug; 143(4):139-41. PubMed ID: 4021907
[TBL] [Abstract][Full Text] [Related]
7. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
Booth F; Barker LC; Barton CJ; Naik RB
Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
[TBL] [Abstract][Full Text] [Related]
8. Maloprim and agranulocytosis.
Bruce-Chwatt LJ; Hutchinson DB
Lancet; 1983 Dec 24-31; 2(8365-66):1487-8. PubMed ID: 6140569
[No Abstract] [Full Text] [Related]
9. Agranulocytosis associated with Maloprim.
Bruce-Chwatt LJ; Hutchinson DB
Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65-6. PubMed ID: 6418319
[No Abstract] [Full Text] [Related]
10. Chemoprophylaxis of malaria in Africa.
Rée GH
Br Med J (Clin Res Ed); 1983 Feb; 286(6364):562. PubMed ID: 6402151
[No Abstract] [Full Text] [Related]
11. Maloprim for malaria prophylaxis.
Donovan KD
Med J Aust; 1985 Sep; 143(7):319-20. PubMed ID: 4046929
[No Abstract] [Full Text] [Related]
12. Adverse reactions to Fansidar.
Kollisch DO
J Fam Pract; 1986 Sep; 23(3):202-4. PubMed ID: 2943869
[No Abstract] [Full Text] [Related]
13. Pulmonary toxicity of malaria prophylaxis.
Davidson AC; Bateman C; Shovlin C; Marrinan M; Burton GH; Cameron IR
BMJ; 1988 Nov; 297(6658):1240-1. PubMed ID: 3145065
[No Abstract] [Full Text] [Related]
14. Agranulocytosis associated with malaria prophylaxis with Maloprim.
Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
[No Abstract] [Full Text] [Related]
15. Idiosyncratic reaction resembling toxic epidermal necrolysis caused by chloroquine and maloprim.
Phillips-Howard PA; Warwick Buckler J
Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1605. PubMed ID: 3135033
[No Abstract] [Full Text] [Related]
16. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Lee PS; Lau EY
Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
[No Abstract] [Full Text] [Related]
18. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
Thong BY; Leong KP; Chng HH
Ann Allergy Asthma Immunol; 2002 May; 88(5):527-9. PubMed ID: 12027077
[TBL] [Abstract][Full Text] [Related]
19. [The reliability and side effects of malaria chemoprophylaxis].
Steffen R; Heusser R
Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
[No Abstract] [Full Text] [Related]
20. Agranulocytosis associated with maloprim: review of cases.
Hutchinson DB; Whiteman PD; Farquhar JA
Hum Toxicol; 1986 Jul; 5(4):221-7. PubMed ID: 3733111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
